Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Adolescents with Bipolar Disorder
2024-516713-21-00Phase 3Completed
- Sponsor
- Ospedale Pediatrico Bambino Gesù
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Memantine Accord with Placebo (2 arms). Started Nov 2024; status: completed.
02
Drugs
memantine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2024-516713-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516713-21-00.